RJ Noecker, ML Earl, TK Mundorf, SM … - Current Medical Research and Opinion®, 2006 - informahealthcare.com Objective: To compare the intraocular pressure- lowering efficacy and safety of
topical bimatoprost 0.03% with that of travoprost 0.004% for the treatment of
black patients with open-angle glaucoma (OAG) and ocular hypertension ... Cited by 5 - Related articles - BL Direct - All 5 versions
F Aptel, M Cucherat, P Denis - Journal of Glaucoma, 2008 - journals.lww.com Florent Aptel, MD,* Michel Cucherat, MD,w and Philippe Denis, MD, PhD* ... Aim:
This systematic meta-analysis was performed to evaluate the intraocular pressure
(IOP) lowering effects and tolerability of latanoprost, bimatoprost, and ... Cited by 5 - Related articles - All 2 versions
- ►pubget.com [PDF] T Alasbali, M Smith, N Geffen, GE Trope, JG … - American Journal of Ophthalmology, 2009 - Elsevier English publications comparing the ocular hypotensive efficacy between any or
all of latanoprost, travoprost, and bimatoprost were searched from the MEDLINE
database. Each article was reviewed by three independent observers and was ... Cited by 3 - Related articles - All 25 versions
M Blini, GCM Rossi, G Trabucchi, MR Curatola, … - Current Medical Research and Opinion®, 2008 - informahealthcare.com Objective: To evaluate the intraocular pressure (IOP) lowering efficacy and
safety of travoprost 0.004% in patients with open-angle glaucoma or ocular
hypertension, poorly controlled with or intolerance to beta-blockers. To ... Cited by 1 - Related articles - All 5 versions
P Denis, D Covert, A Realini, 2007 - pubmedcentral.nih.gov Travoprost is a member of the prostaglandin analogue class of intraocular
pressure (IOP)-lowering drugs used to treat ocular hypertension and glaucoma.
Like other prostaglandin analogues, travoprost lowers IOP by enhancing the ... Cited by 2 - Related articles - All 6 versions
E Arranz-Marquez, MA Teus - Expert Opin. Drug Saf., 2008 - informahealthcare.com Background: Prostanoids are the newest pharmacologic group of ocular hypotensive
drugs for clinical management of glaucoma. The group includes four chemical
compounds structurally derived from naturally-occurring prostaglandin (PG) ... Cited by 1 - Related articles - All 6 versions
MA Teus, E Arranz-Marquez - Expert Review of Ophthalmology, 2008 - ingentaconnect.com Prostaglandin F2α analogues are the most recent class of ocular hypotensive
drugs that have become available for clinical use in patients with glaucoma. The
terms 'prostanoids' and 'prostaglandin analogues' have been used to ... Related articles - All 3 versions
O Eyawo, J Nachega, P Lefebvre, D Meyer, B …, 2009 - pubmedcentral.nih.gov A meta-analysis was conducted of head-to-head randomized trials of prostaglandin
therapies. We included randomized trials assessing head-to-head evaluations of
prostaglandin analogues travoprost, latanoprost and bimatoprost in patients ... Related articles - All 5 versions
J Kammer, B Katzman, S Ackerman… - bjo.bmj.com Page 1. doi: 10.1136/bjo.2009.158071 published online September 1, 2009 Br J
Ophthalmol Jeffrey Kammer, Barry Katzman, Stacey Ackerman, et al. ... Related articles